U.S. Oil and Gas Stock News

Knowles (NYSE:KN) is facing long term operational headwinds, with sales and earnings growth trailing the broader business services sector. Recent analysis points to a persistent decline in revenue and weaker earnings per share growth compared with industry peers. These pressures raise questions about the company’s competitive position and long term resilience beyond earlier valuation focused coverage. Knowles, trading at $34.07, has seen its share price move sharply over time, with the...

In the first quarter of 2026, Stoke Therapeutics, Inc. reported sales of US$6.23 million and a net loss of US$50 million, reversing from much higher revenue and a net profit a year earlier. This sharp swing from earnings per share of about US$1.90–US$1.95 to a basic loss of US$0.79 highlights how rapidly the company’s financial profile can shift as it advances its RNA medicines pipeline. We’ll now examine how this abrupt move from profit to loss in the latest quarter reshapes Stoke...

On 14 May 2026, Casella Waste Systems and Waga Energy marked the opening of a WAGABOX-powered facility at Chemung County Landfill in Elmira, New York, which has been converting landfill gas into pipeline-quality renewable natural gas since January and supplying it directly into the Valley Energy network. This project, designed to generate up to 610,000 MMBtu of renewable gas annually while avoiding more than 47,000 tons of CO2-equivalent emissions, underpins Casella’s effort to turn waste...

Middleby recently announced that its Food Processing business will be separated into a standalone public company, Midera Food Processing Inc., via a distribution of Midera shares to existing Middleby stockholders, with completion expected in early July 2026 subject to regulatory approvals. This move reshapes Middleby into a more focused equipment group while giving investors direct exposure to a pure play food processing company with its own identity and capital structure. We’ll now examine...

In the past quarter, Upbound Group reported Q1 results that exceeded earnings expectations and reaffirmed its guidance for ongoing profitability, easing some concerns about pressure on lower-income customers. The combination of stronger-than-expected performance, maintained outlook, and analyst upgrades has drawn attention to Upbound’s elevated dividend yield as a key feature of its investment case. We’ll now examine how this earnings beat and reaffirmed profitability guidance may reshape...

Papa John's International (NasdaqGS:PZZA) is rolling out its Special Garlic Dipping Sauce to major U.S. grocery chains nationwide. The retail launch includes placement in large banners such as Walmart and Kroger for the first time. This is the company’s first effort to sell a signature menu item through consumer packaged goods channels. Papa John's International enters this grocery launch with its stock at $33.35 and multi year returns that have moved lower, including down 50.2% over 3...

Allegiant Travel stock: recent performance snapshot Allegiant Travel (ALGT) has drawn investor attention after a period of weaker share performance, with the stock down 24% over the past month and 36% over the past 3 months. See our latest analysis for Allegiant Travel. That weak 1 day share price return of 6.42% caps a tougher stretch for Allegiant Travel, with the stock down 20.61% year to date. Yet the 1 year total shareholder return of 26.10% shows a very different longer term picture,...

Some AAON, Inc. ( NASDAQ:AAON ) shareholders may be a little concerned to see that the President, Matthew Tobolski...

What CVR Energy stock’s recent move tells you CVR Energy (CVI) has drawn fresh attention after recent trading left the stock at a last close of US$34.34, with strong gains over the past month and past 3 months. See our latest analysis for CVR Energy. While the 1-day share price return slipped 0.58%, CVR Energy’s recent momentum remains strong, with a 30-day share price return of 16.64% and a 1-year total shareholder return of 48.20%. This indicates sentiment has shifted materially over the...

BioMarin Pharmaceutical (NasdaqGS:BMRN) reported that BMN 401 missed one of two co-primary endpoints in the Phase 3 ENERGY 3 trial for ENPP1 deficiency. The therapy did not show improvement in skeletal health or key secondary outcomes, raising questions about its regulatory and commercial outlook. The result affects BioMarin's rare disease pipeline at a time when the company is working to broaden its revenue base beyond existing treatments. For investors watching rare disease drug...

Cathie Wood's ARK Invest and Ken Griffin have recently added to their positions in Joby Aviation (NYSE:JOBY). The increased holdings come ahead of Joby's planned launch of commercial air taxi services. These investments arrive as Joby reports progress on key FAA certification steps and commercial partnerships. The fresh backing contrasts Joby with competitor Archer Aviation and highlights changing market sentiment toward air taxis. Joby Aviation, trading under NYSE:JOBY, is working on...

Wondering if Danaos at around US$129.81 is still offering value, or if most of the opportunity is already priced in? This article walks through the key signals to help you frame that question clearly. The stock has been relatively active, with the share price down about 2.3% over the past week, up 10.2% over 30 days, up 36.3% year to date, and showing a 58.3% return over the last year, alongside very large multi year gains of more than 7x over five years. These swings in the share price have...

ImmunityBio (NasdaqGS:IBRX) received FDA acceptance for review of its supplemental Biologics License Application for ANKTIVA plus BCG in BCG-unresponsive non-muscle invasive bladder cancer with papillary disease. The company also released new comparison data indicating improved efficacy and safety of ANKTIVA plus BCG versus other approved bladder cancer therapies, presented at a major medical meeting. These developments relate to a potential expansion of ANKTIVA's approved use and could...

In early May 2026, Alignment Healthcare amended its bylaws to create a Vice Chair role as founder and CEO John Kao became Chairman, while longtime director Joseph Konowiecki moved to Vice Chairman and Executive Vice President of Corporate Affairs alongside new senior hires for the COO and MSO President positions. Around the same time, Alignment Healthcare was added to multiple S&P indices, including the S&P SmallCap 600 and S&P Composite 1500, potentially broadening its investor base and...

MDU Resources Group (MDU) has been drawing attention after recent share price moves. This activity is supported by fresh data points on returns, revenue and net income that give investors more to work with. See our latest analysis for MDU Resources Group. Despite a small pullback in the latest session, with a 1-day share price return that declined 0.85% to US$22.29, MDU Resources Group still has a 30-day share price return of 2.44%, a 90-day share price return of 9.48%, and a 1-year total...

Commvault Systems (CVLT) is back under the spotlight after a class action lawsuit alleged that past statements about the sustainability of its recurring revenue growth were misleading, following third quarter 2026 net new ARR coming in below guidance. See our latest analysis for Commvault Systems. Against the backdrop of the lawsuit and recent Form 144 insider sale filings, Commvault Systems’ share price closed at US$101.97, with a 30 day share price return of 8.21% and a year to date share...

Investors may be wondering whether Installed Building Products, at around US$204 per share, still offers value or whether most of the opportunity is already priced in. The stock is up 0.9% over the past week, even after a 31.3% decline over the last month and a 23.5% decline year to date. The 1 year and 3 year returns of 28.5% and 97.9% illustrate how different timeframes can tell very different stories. Recent coverage has focused on Installed Building Products as a US residential and...

Earlier this month, Atlas Energy Solutions Inc. filed a US$112.08 million shelf registration for 6,000,000 common shares tied to an ESOP-related offering, while institutional investor Encompass Capital reported owning more than 7% of the company. These moves, alongside stronger-than-expected quarterly revenue and EBITDA despite a GAAP loss, highlight how operational performance and ownership shifts are reshaping Atlas Energy Solutions’ risk–reward profile. With stronger-than-expected revenue...

Vishay Intertechnology, Inc.'s ( NYSE:VSH ) stock was strong after they recently reported robust earnings. However, we...

Shareholders appeared unconcerned with ICL Group Ltd's ( NYSE:ICL ) lackluster earnings report last week. We did some...

Alset Inc.'s (NASDAQ:AEI) value has fallen 16% in the last week, but insiders who sold US$2.7m worth of stock over the...

In recent days, Bank of America resumed coverage of Salesforce with an Underperform rating, arguing that AI is driving a structural reset in the business as muted new customer additions, limited upsell opportunities, and questions around monetizing Agentforce and other AI products point to a slower-growth, cash-generative profile. At the same time, Salesforce continues to sign AI-focused deals and partnerships, from Anthropic token spending and Pearson workforce skilling to Agentforce wins...

ReNew Energy Global (NasdaqGS:RNW) has just wrapped up FY 2026 with fourth quarter revenue of ₹31.8b and basic EPS of ₹2.13, while trailing twelve month EPS stands at ₹28.56 on revenue of ₹132.2b and net income of ₹10.4b. Over the past few quarters, revenue has ranged from ₹25.1b to ₹39.0b with quarterly EPS swinging between a loss of ₹0.54 and a gain of ₹14.14. This gives investors a clear view of how earnings power has tracked alongside top line performance. With trailing net margins higher...

In May 2026, Dynatrace reported fourth-quarter revenue of US$531.72 million and full-year revenue of US$2.02 billion, but net income dropped to US$17.42 million for the quarter and US$162.67 million for the year, partly reflecting an US$18.53 million impairment of long-lived assets. At the same time, Dynatrace paired this weaker profitability with new guidance calling for US$2.32–US$2.34 billion in fiscal 2027 revenue and completed more than US$651 million of share repurchases since 2024,...